Science

Segev Harel, 26, from northern Israel, becomes the first Israeli volunteer to get the coronavirus vaccine developed by the Israel Institute for Biological Research.

Sheba's new telemedicine center is running pilot studies to change the way the medical world approaches women's health.

The Israel Institute for Biological Research will begin a 3-phase clinical trial with human participants for its vaccine candidate, Brilife.

Kamada developed a plasma-derived, investigational antibody treatment for COVID-19 currently under trial; interim results show promise.

Israeli pharmaceutical company Mileutis develops non-antibiotic treatment and prevention products for animal and human health.

The Israeli company will integrate its AI-based diabetes treatment solution to health clinics in Montana, New York, California, and Florida.

In a new study, scientists from Germany found latrines a valuable source of historical data, which may aid understanding of today’s diseases.

A team of Israeli researchers have isolated six antibodies that work in combination to target the coronavirus and neutralize it.

If the Alzheimer's treatment is successful, it could be a game-changer for the disorder, modifying its course and preventing its progression.

Diagnostic Robotics' system aims to alleviate strained health budgets and workforces by optimizing patient navigation.

The new agreement will grant Terumo exclusive rights to distribute IceCure products in Thailand over the course of six years.

Professor Regina Barzilay is being honored for her work using ML models to detect and predict cancer, and accelerate drug development.

Tel Aviv Sourasky Center is the first Israeli hospital to use a platform developed by a company that wants to improve surgical performance.

Novellus tailors actionable cancer treatment for patients through the development of a drug that delays the BRAF gene mutation.

Rambam and Beilinson hospitals say they will be able to care for ‘hundreds’ of patients at a time as Israel's second lockdown begins.